GL1X · GenesisL1 explorer

MolNFT v1 · #21907 · protein

Crystal structure of ns-134 in complex with bovine cathepsin B: a two headed epoxysuccinyl inhibitor extends along the whole active site cleft

1SP4: “Crystal structure of ns-134 in complex with bovine cathepsin B: a two headed epoxysuccinyl inhibitor extends…”. X-ray diffraction, 1 ligand (EP2), 1 pocket (best druggability 0.52). MolNFT v1 #21907 on GenesisL1: 3D structure…

PDB
1SP4
Type
protein
Length
253 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Cathepsin B
EC
3.4.22.1
UniProt
P07688
Ligands
EP2
Pockets
1 · best druggability 0.52

Structure

x-ray diffraction · 2 distinct chains · 26% helix, 26% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACathepsin B (EC 3.4.22.1)protein4850% helix, 8% strandP07688
BCathepsin B (EC 3.4.22.1)protein20520% helix, 30% strandP07688

Ligands and binding sites

  • EP2 · methyl N-[(2S)-4-{[(1S)-1-{[(2S)-2-carboxypyrrolidin-1-yl]carbonyl}-3-methylbutyl]amino}-2-hydroxy-4-oxobutanoyl]-L-leucylglycylglycinate · ligand · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11870.520.7828EP2

Interfaces

1 interface between chains.

  • A–B · 2440 Ų buried · 43 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 7 disulfide, 1 covalent (disulfide, covalent ligand).

Compared structures

  • 1SP4 · Crystal structure of NS-134 in complex with bovine cathepsin B: a two headed… · the same entry in another collection · chain A against A, TM-score 1.00
  • P07688 · AlphaFold monomer V2.0 prediction for cathepsin B (P07688) · a predicted model of the same protein · chain B against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.